USPTO serial 88787463
Serial No. 88787463
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 1, 2020
- Examiner
- SMIGA, HOWARD
- Law office
- Historical data usage
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with Serial No. 88787463?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*
Plus Government fees of $1,275
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
East Brunswick, NJ, US
East Brunswick, NJ, US
East Brunswick, NJ, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Matthew A. Homyk
Matthew A. Homyk BLANK ROME LLPONE LOGAN SQUARE8TH FLOORPHILADELPHIA, PA 19103Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of neurological, renal, hematopoietic, thyroid, and ophthalmic diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Anti-inflammatory pharmaceutical preparations; Cardiovascular pharmaceuticals; anti-microbial pharmaceutical preparations; anti-neoplastic pharmaceutical preparations; immunomodulatory pharmaceutical preparations; hematopoietic pharmaceutical preparations; Pharmaceutical preparations, namely, anticoagulants; [ pharmaceutical preparations, namely, thrombolytic agents; antiplatelets, namely, platelet agglutination inhibitors and platelet aggregation inhibitors; Estrogen preparations; pharmaceutical preparations, namely, progestin; Androgen preparations; ] Antithyroid pharmaceutical preparations used to treat hyperthyroidism; Pharmaceutical preparations for treating diabetes; [ pharmaceutical preparations, namely, histamine H2 receptor antagonists and proton pump antagonists; ] anti-emetic pharmaceutical preparations; anti-convulsant pharmaceutical preparations; pharmaceutical preparations for the treatment of asthma; anti-diabetic pharmaceuticals | ACTIVE | Jan 29, 2020 |
| 040 | Custom manufacture of pharmaceuticals for others; providing technical information in the field of pharmaceutical manufacturing | ACTIVE | Jan 29, 2020 |
| 042 | Development of pharmaceutical preparations and medicines | ACTIVE | Jan 29, 2020 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Heritage Pharmaceuticals Inc.
- Other trademarks owned by Heritage Pharmaceuticals Inc.
- Other trademarks owned by Heritage Pharmaceuticals Inc.
- Other trademarks in Class 005
- Other trademarks in Class 040
- Other trademarks in Class 042
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 3, 2026 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Nov 3, 2026 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Nov 2, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Aug 28, 2026 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Sep 1, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Sep 1, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 16, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 16, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 27, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 11, 2020 | ALIE | ASSIGNED TO LIE | — |
| Apr 30, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 30, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 30, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 30, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 30, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 29, 2020 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Apr 29, 2020 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Apr 29, 2020 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Apr 27, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 11, 2020 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Feb 10, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 10, 2020 | NWAP | NEW APPLICATION ENTERED | — |